Pregled bibliografske jedinice broj: 501452
Proposal for biologic drugs therapy in rheumatoid arthritis
Proposal for biologic drugs therapy in rheumatoid arthritis // Reumatizam, 57 (2010), 1; 29-35 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 501452 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Proposal for biologic drugs therapy in rheumatoid arthritis
Autori
Curković, B ; Babić-Naglić, D ; Morović-Vergles, J ; Anić, B ; Grazio, S ; Kaliterna, DM ; Hanih, M ; Novak, Srđan
Izvornik
Reumatizam (0374-1338) 57
(2010), 1;
29-35
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
biologic drugs therapy; rheumatoid arthritis
Sažetak
Rheumatoid arthritis is a chronic, inflammatory disease with the prevalence about 1%. Rheumatoid arthritis is characterized with synovitis, often evolve erosions of the joints, pain and functional deficit. Etiology is unknown, but the development of such autoimmune disease is due to genetic and environmental factors. Most of the patients with diagnosis of rheumatoid arthritis use nonbiologic disease modifying antirheumatic drugs. Advances in the undersstanding of the disease process have led to the development of biological agents to treat rheumatoid arthritis. With the use of biologic agents we wish to evolve the goal of therapy from that of symptomatiic relief to clinical remission. Biologic drugs have documented, fast and continuous efficacy with generaly well accepted safety profile. On behalf of Croatian Society for Rheumatology we propose recommendations for the biologic therapy in rheumatoid arthritis.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Profili:
Jadranka Morović-Vergles
(autor)
Boris Ćurković
(autor)
Đurđica Babić-Naglić
(autor)
Branimir Anić
(autor)
Srđan Novak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE